Skip to main content

UPDATE 1-Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A

PARIS, Feb 8 (Reuters) - France's biggest drugmaker, Sanofi , which missed out on a major takeover deal last month, said on Wednesday it expected 2017 earnings per share to be stable or slightly lower.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.